Immunomodulation in multiple sclerosis: promises and pitfalls

Immunomodulation in multiple sclerosis: promises and pitfalls

Multiple sclerosis (MS) afflicts about 2.5 million people globally and poses a major personal and socioeconomic burden. The recognition of MS as an inflammatory disease, characterized by infiltration of immune cells into the central nervous system, has spurred research into the autoimmune etiology o...

Bibliografske podrobnosti
Main Authors:	Dendrou, C, Fugger, L
Format:	Journal article
Jezik:	English
Izdano:	Elsevier 2017

Podobne knjige/članki

A clinical conundrum: the detrimental effect of TNF antagonists in multiple sclerosis.
od: Dendrou, C, et al.
Izdano: (2013)

Bridging the gap from genetic association to functional understanding: the next generation of mouse models of multiple sclerosis.
od: Attfield, K, et al.
Izdano: (2012)

Meningioma after immunomodulation for multiple sclerosis
od: Rodrigo Gonçalves Kleinpaul Vieira, et al.
Izdano: (2012-01-01)

Immunomodulation and postpartum relapses in patients with multiple sclerosis
od: Kerstin Hellwig, et al.
Izdano: (2009-01-01)

Clinical predictors of response to immunomodulators for multiple sclerosis
od: Guilherme Sciascia do Olival, et al.
Izdano: (2012-01-01)

Potential Application of Tregitopes as Immunomodulating Agents in Multiple Sclerosis
od: Wassim Elyaman, et al.
Izdano: (2011-01-01)

Current Status of the Immunomodulation and Immunomediated Therapeutic Strategies for Multiple Sclerosis
od: Shyi-Jou Chen, et al.
Izdano: (2012-01-01)

Factors associated with adherence to immunomodulator treatment in people with multiple sclerosis
od: Nair Assunta Antônia Corso Câmara, et al.
Izdano: (2017-04-01)

The promise and pitfalls of synteny in phylogenomics.
od: Jacob L Steenwyk, et al.
Izdano: (2024-05-01)

The Promise and Pitfalls of Self-report
od: Luke K. Fryer, et al.
Izdano: (2020-03-01)

Immunomodulating Treatment of Multiple Sclerosis — the Tasks and Role of a Neurological Nurse
od: Anna Smelkowska, et al.
Izdano: (2018-06-01)

Cerebrovascular reactivity in multiple sclerosis is restored with reduced inflammation during immunomodulation
od: Antonio Maria Chiarelli, et al.
Izdano: (2022-09-01)

The Promises and Pitfalls of 311 Data
od: White, Ariel R., et al.
Izdano: (2020)

e-Portfolios: Promises & Pitfalls
od: Natasha Boskic
Izdano: (2006-02-01)

The promises and pitfalls of specifying situatedness
od: Greenhough, B
Izdano: (2019)

T cells and microglia as drivers of multiple sclerosis pathology.
od: Friese, M, et al.
Izdano: (2007)

T cells and microglia as drivers of multiple sclerosis pathology
od: Friese, M, et al.
Izdano: (2007)

Pathogenic CD8(+) T cells in multiple sclerosis.
od: Friese, M, et al.
Izdano: (2009)

The immunology of multiple sclerosis
od: Attfield, KE, et al.
Izdano: (2022)

Personalised medicine: the promise, the hype and the pitfalls
od: Feiler, T, et al.
Izdano: (2017)

Platform ad archives: promises and pitfalls
od: Paddy Leerssen, et al.
Izdano: (2019-10-01)

Promise and pitfalls of the cancer biomarker search
od: Sarah A. Webb
Izdano: (2010-08-01)

ChatGPT in psychiatry: promises and pitfalls
od: Rebecca Shin-Yee Wong
Izdano: (2024-01-01)

On-line education in Africa: promises and pitfalls
od: Anthony Lelliott, et al.
Izdano: (2001-12-01)

Brain Targeting Nanomedicines: Pitfalls and Promise
od: Kakinen A, et al.
Izdano: (2024-05-01)

Promising treatments of tomorrow for multiple sclerosis
od: Harrison Daniel, et al.
Izdano: (2009-01-01)

Delivering language intervention at scale: promises and pitfalls
od: Snowling, MJ, et al.
Izdano: (2022)

Delivering language intervention at scale: promises and pitfalls
od: Snowling, M, et al.
Izdano: (2022)

Restructuring the FDA’s Food Program: Promises and Pitfalls
od: Sammer Marzouk, et al.
Izdano: (2024-10-01)

Big data tip the scale
od: Dendrou, C, et al.
Izdano: (2013)

Weighing in on autoimmune disease: Big data tip the scale.
od: Dendrou, C, et al.
Izdano: (2013)

Weighing in on autoimmune disease: Big data tip the scale.
od: Dendrou, C, et al.
Izdano: (2013)

Editorial: Pharmacotherapy of Anxiety Disorders: Promises and Pitfalls
od: Amir Garakani, et al.
Izdano: (2021-03-01)

Selective Brain Network and Cellular Responses Upon Dimethyl Fumarate Immunomodulation in Multiple Sclerosis
od: Dumitru Ciolac, et al.
Izdano: (2019-07-01)

Misfiring in multiple sclerosis: cerebellar channelopathy, a potential novel target?
od: Craner, M, et al.
Izdano: (2012)

Medicinal Herbs: Promising Immunomodulators for the Treatment of Infectious Diseases
od: Hamad H. Alanazi, et al.
Izdano: (2023-12-01)

Promises and pitfalls of China-Southeast Asia energy connectivity
od: Laurence L. Delina
Izdano: (2021-01-01)

Promises and Pitfalls in the Use of PD-1/PD-L1 Inhibitors in Multiple Myeloma
od: Stefania Oliva, et al.
Izdano: (2018-11-01)

Interleukin-17 expression in multiple sclerosis
od: Tzartos, J, et al.
Izdano: (2006)

A review on metaanalysis of biomarkers: promises and pitfalls.
od: Lewington, S, et al.
Izdano: (2012)